• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Contemporary problems in the epidemiology and clinical pathology of leprosy].

作者信息

Kociecka W

机构信息

Klinika Chorób Pasozytniczych, Poznań.

出版信息

Wiad Parazytol. 1995;41(4):373-90.

PMID:8834501
Abstract

Contemporary problems have been presented, related to pathogenesis, clinical pathology and epidemiology of leprosy. It has been stressed that intensity of cell mediated immune response in the patient determines not only resistance or susceptibility to infection with Mycobacterium leprae but also defines traits of clinical pathology in leprosy, thus providing the basis for modern clinical classification. Present aims and investigative methods in lepra epidemiology have been shown. Current data have been provided on spread of leprosy in various parts of the world, mainly those remaining under monitoring by the World Health Organization. The data point to significant decrease in registered leprosy cases in the regions beginning from 1986 and, in particular, in years 1990-1994. The decrease has resulted from adequate verification of the disease stage in the patients and from applying the recommended multidrug therapy. The needs and perspectives of actions aiming at combatting leprosy have been described, aiming at eradication of leprosy as the international health problem till the year 2000. It has been stressed that at present, leprosy is no longer a hopeless disease and that it can be cured when sufficiently early diagnosed and properly treated.

摘要

相似文献

1
[Contemporary problems in the epidemiology and clinical pathology of leprosy].
Wiad Parazytol. 1995;41(4):373-90.
2
Leprosy: diagnostic and control challenges for a worldwide disease.麻风病:一种全球性疾病的诊断与控制挑战
Arch Dermatol Res. 2008 Jul;300(6):269-90. doi: 10.1007/s00403-008-0857-y. Epub 2008 May 7.
3
The impact of leprosy control on the transmission of M. leprae: is elimination being attained?麻风病控制对麻风分枝杆菌传播的影响:是否正在实现消除目标?
Lepr Rev. 2007 Dec;78(4):330-7.
4
[Eradication of leprosy and public health. Vaccination and multidrug therapy].[麻风病的根除与公共卫生。疫苗接种与联合化疗]
Przegl Epidemiol. 2002;56(4):577-86.
5
Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.在THELEP对照临床药物试验中对多药治疗方案的反应。联合国开发计划署/世界银行/世界卫生组织热带病研究和培训特别规划麻风病化疗临床试验小组委员会(THELEP)科学工作组。
Lepr Rev. 1996 Dec;67(4):260-79.
6
Molecular biological assessment methods and understanding the course of the HIV infection.分子生物学评估方法与对HIV感染病程的理解
APMIS Suppl. 2003(114):1-37.
7
Multidrug therapy--the pathway for global leprosy elimination.联合化疗——全球消除麻风病的途径。
Indian J Lepr. 2000 Oct-Dec;72(4):477-90.
8
Relapses in multibacillary leprosy patients after multidrug therapy.多菌型麻风患者在接受多药联合治疗后的复发情况。
Lepr Rev. 2008 Sep;79(3):320-4.
9
The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.来自缅甸、印度尼西亚和菲律宾的未经治疗及复发麻风病患者中麻风分枝杆菌分离株的耐药突变频率。
Lepr Rev. 2007 Dec;78(4):343-52.
10
A overview of ocular leprosy after 2 decades of multidrug therapy.经过二十年多药疗法后的眼部麻风病概述。
Int Ophthalmol Clin. 2007 Summer;47(3):87-101. doi: 10.1097/IIO.0b013e318074e3eb.